Rosenthal Eben L, Warram Jason M, Bland Kirby I, Zinn Kurt R
*Departments of Surgery and †Radiology, The University of Alabama at Birmingham, Birmingham, AL.
Ann Surg. 2015 Jan;261(1):46-55. doi: 10.1097/SLA.0000000000000622.
To review the current trends in optical imaging to guide oncologic surgery.
Surgical resection remains the cornerstone of therapy for patients with early stage solid malignancies and more than half of all patients with cancer undergo surgery each year. The technical ability of the surgeon to obtain clear surgical margins at the initial resection remains crucial to improve overall survival and long-term morbidity. Current resection techniques are largely based on subjective and subtle changes associated with tissue distortion by invasive cancer. As a result, positive surgical margins occur in a significant portion of tumor resections, which is directly correlated with a poor outcome.
A comprehensive review of studies evaluating optical imaging techniques is performed.
A variety of cancer imaging techniques have been adapted or developed for intraoperative surgical guidance that have been shown to improve functional and oncologic outcomes in randomized clinical trials. There are also a large number of novel, cancer-specific contrast agents that are in early stage clinical trials and preclinical development that demonstrate significant promise to improve real-time detection of subclinical cancer in the operative setting.
There has been an explosion of intraoperative imaging techniques that will become more widespread in the next decade.
回顾光学成像的当前趋势以指导肿瘤手术。
手术切除仍然是早期实体恶性肿瘤患者治疗的基石,每年超过一半的癌症患者接受手术。外科医生在初次切除时获得清晰手术切缘的技术能力对于提高总体生存率和长期发病率仍然至关重要。当前的切除技术很大程度上基于与浸润性癌导致的组织变形相关的主观和细微变化。因此,在相当一部分肿瘤切除术中会出现手术切缘阳性,这与不良预后直接相关。
对评估光学成像技术的研究进行全面综述。
多种癌症成像技术已被改编或开发用于术中手术指导,在随机临床试验中已证明可改善功能和肿瘤学结果。还有大量新型的、针对癌症的造影剂正处于早期临床试验和临床前开发阶段,显示出在手术环境中改善亚临床癌症实时检测的巨大潜力。
术中成像技术呈爆发式增长,在未来十年将变得更加普及。